The activator protein 1 binding motifs within the human cytomegalovirus major immediate-early enhancer are functionally redundant and act in a cooperative manner with the NF-κB sites during acute infection

Journal of Virology

Volumn 85, Issue 4, 2011, Pages 1732-1746

  Isern, Elena ^a   Gustems, Montse ^a,d   Messerle, Martin ^b   Borst, Eva ^b   Ghazal, Peter ^c   Angulo, Ana ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HETERODIMER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL TYPE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; EMBRYO; GENE DISRUPTION; GENETIC TRANSFECTION; HUMAN CYTOMEGALOVIRUS; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN MOTIF; SITE DIRECTED MUTAGENESIS; VIROGENESIS; VIRUS GENOME; VIRUS INACTIVATION; VIRUS INFECTIVITY; VIRUS MUTATION; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS VIRULENCE;

ACUTE DISEASE; AMINO ACID MOTIFS; ANIMALS; BINDING SITES; CELL LINE; CELL LINE, TUMOR; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; ENHANCER ELEMENTS, GENETIC; GENES, IMMEDIATE-EARLY; HUMANS; IMMEDIATE-EARLY PROTEINS; MICE; MICE, INBRED BALB C; MUROMEGALOVIRUS; MUTAGENESIS, SITE-DIRECTED; NF-KAPPA B; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RESPONSE ELEMENTS; TRANSCRIPTION FACTOR AP-1; VIRUS REPLICATION;

HUMAN HERPESVIRUS 5; MURINAE; MUS;

EID: 78951478406     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01713-10     Document Type: Article

References (65)

1. Amicone, L., et al. 1997. Transgenic expression in the liver of truncated Met blocks apoptosis and permits immortalization of hepatocytes. EMBO J. 16:495-503. (Pubitemid 27067779)
2. Angel, P., and M. Karin. 1991. The role of Jun, Fos, and the AP-1 complex in cell proliferation and transformation. Biochim. Biophys. Acta 1072:129-157.
3. Angel, P., et al. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729-739.
4. Angulo, A., M. Messerle, U. H. Koszinowski, and P. Ghazal. 1998. Enhancer requirement for murine cytomegalovirus growth and genetic complementation by the human cytomegalovirus enhancer. J. Virol. 72:8502-8509. (Pubitemid 28471786)
5. Baskar, J. F., et al. 1996. Developmental analysis of the cytomegalovirus enhancer in transgenic animals. J. Virol. 70:3215-3226.
6. Baskar, J. F., et al. 1996. The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J. Virol. 70:3207-3214.
7. Benedict, C. A., et al. 2004. Neutrality of the canonical NF-κB-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro. J. Virol. 78:741-750.
8. Boldogh, L., S. AbuBakar, and T. Albrecht. 1990. Activation of proto-oncogenes: an immediate early event in human cytomegalovirus infection. Science 247:561-564. (Pubitemid 20073677)
9. Boldogh, L., S. AbuBakar, C. Z. Deng, and T. Albrecht. 1991. Transcriptional activation of cellular oncogenes fos, jun, and myc by human cytomegalovirus. J. Virol. 65:1568-1571.
10. Boldogh, L., M. P. Fons, and T. Albrecht. 1993. Increased levels of sequencespecific DNA-binding proteins in human cytomegalovirus-infected cells. Biochem. Biophys. Res. Commun. 197:1505-1510.
11. Borst, E. M., and M. Messerle. 2000. Development of a cytomegalovirus vector for somatic gene therapy. Bone Marrow Transplant. 25:80-82.
12. Borst, E. M., and M. Messerle. 2005. Analysis of human cytomegalovirus oriLyt sequence requirements in the context of the viral genome. J. Virol. 79:3615-3626.
13. Borst, E. M., C. Benkartek, and M. Messerle. 2007. Use of bacterial artificial chromosomes in generating targeted mutations in human and mouse cytomegaloviruses. Curr. Protoc. Immunol. 77:10.32.1-10.32.30.
14. Borst, E., G. Hahn, U. H. Koszinowski, and M. Messerle. 1999. Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants. J. Virol. 73:8320-8329. (Pubitemid 29441693)
15. Boshart, M., et al. 1985. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41:521-530. (Pubitemid 16219422)
16. Caposio, P., A. Luganini, G. Hahn, S. Landolfo, and G. Gribaudo. 2007. Activation of the virus-induced IKK/NF-kB signalling axis is critical for the replication of human cytomegalovirus in quiescent cells. Cell. Microbiol. 9:2040-2054.
17. Caposio, P., A. Luganini, M. Bronzini, S. Landolfo, and G. Gribaudo. 2010. The Elk-1 and serum response factor binding sites in the major immediateearly promoter of human cytomegalovirus are required for efficient viral replication in quiescent cells and compensate for inactivation of the NFkappaB sites in proliferating cells. J. Virol. 84:4481-4493.
18. Cook, C. H., J. Trgovcich, P. D. Zimmerman, Y. Zhang, and D. D. Sedmak. 2006. Lipopolysaccharide, tumor necrosis alpha, or interleukin-1 beta triggers reactivation of latent cytomegalovirus in immunocompetent mice. J. Virol. 80:9151-9158.
19. Dorsch-Hasler, K., et al. 1985. A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus. Proc. Natl. Acad. Sci. U. S. A. 82:8325-8329.
20. Eferl, R., and E. F. Wagner. 2003. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3:859-868.
21. Ghazal, P., et al. 1992. Retinoic acid receptors initiate induction of the cytomegalovirus enhancer in embryonal cells. Proc. Natl. Acad. Sci. U. S. A. 89:7630-7634.
22. Ghazal, P., and J. A. Nelson. 1991. Enhancement of RNA polymerase II initiation complex by a novel DNA control domain downstream from the cap site of the cytomegalovirus major immediate-early promoter. J. Virol. 65: 2299-2307.
23. Ghazal, P., and J. A. Nelson. 1993. Transcription factors and viral regulatory proteins as potential mediators of human cytomegalovirus pathogenesis, p. 360-383. In Y. Becker, G. Darai, and E.-S. Huang (ed.), Molecular aspects of human cytomegalovirus diseases. Springer-Verlag Publishers, Heidelberg, Germany.
24. Ghazal, A., M. Messerle, K. Osborn, and A. Angulo. 2003. An essential role of the enhancer for murine cytomegalovirus in vivo growth and pathogenesis. J. Virol. 77:3217-3228.
25. Grzimek, N. K., et al. 1999. In vivo replication of recombinant murine cytomegalovirus driven by the paralogous major immediate-early promoterenhancer of human cytomegalovirus. J. Virol. 73:5043-5055.
26. Gustems, M., A. Busche, M. Messerle, P. Ghazal, and A. Angulo. 2008. In vivo competence of murine cytomegalovirus under the control of the human cytomegalovirus major immediate-early enhancer in the establishment of latency and reactivation. J. Virol. 82:10302-10307.
27. Gustems, M., et al. 2006. Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NF-κB binding sites in the enhancer. J. Virol. 80:9899-9904. (Pubitemid 44435665)
28. Hagemeier, C., S. M. Walker, P. J. G. Sissons, and J. H. Sinclair. 1992. The 72K IE1 and 80K IE2 proteins of human cytomegalovirus independently trans-activate the c-fos, c-myc and hsp70 promoters via basal promoter elements. J. Gen. Virol. 73:2385-2393.
29. Hudson, J. B. 1988. Further studies on the mechanism of centrifugal enhancement of cytomegalovirus infectivity. J. Virol. Methods 19:97-108.
30. Hummel, M., and M. M. Abecassis. 2002. A model for reactivation of CMV from latency. J. Clin. Virol. 25:S123-S136.
31. Hummel, M., et al. 2001. Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency. J. Virol. 75:4814-4822.
32. Isomura, H., et al. 2005. Two sp1/sp3 binding sites in the major immediateearly proximal enhancer of human cytomegalovirus have a significant role in viral replication. J. Virol. 79:9597-9607.
33. Isomura, H., T. Tsurumi, and M. F. Stinski. 2004. Role of the proximal enhancer of the major immediate-early promoter in human cytomegalovirus replication. J. Virol. 78:12788-12799.
34. Isomura, H., and M. F. Stinski. 2003. The human cytomegalovirus major immediate-early enhancer determines the efficiency of immediate-early gene transcription and viral replication in permissive cells at low multiplicity of infection. J. Virol. 77:3602-3614.
35. Jordan, M. C., and V. L. Mar. 1982. Spontaneous activation of latent cytomegalovirus from murine spleen explants: role of lymphocytes and macrophages in release and replication of virus. J. Clin. Invest. 70:762-768.
36. Karin, M., and M. Delhase. 1998. JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action? Proc. Natl. Acad. Sci. U. S. A. 95:9067-9069.
37. Keller, M. J., D. G. Wheeler, E. Cooper, and J. L. Meier. 2003. Role of the human cytomegalovirus immediate-early promoter's 19-base-pair-repeat cyclic AMP-response element in acutely infected cells. J. Virol. 77:6666-6675.
38. Keller, M. J., et al. 2007. Reversal of human cytomegalovirus major immediate- early enhancer/promoter silencing in quiescently infected cells via the cyclic AMP signalling pathway. J. Virol. 81:6669-6681.
39. Kim, S., et al. 1999. Human cytomegalovirus IE1 protein activates AP-1 through a cellular kinase(s). J. Gen. Virol. 80:961-969.
40. Kim, S. J., et al. 2005. Renal ischemia/reperfusion injury activates the enhancer domain of the human cytomegalovirus major immediate early promoter. Am. J. Transplant. 5:1606-1613.
41. Koedood, M., A. Fichtel, P. Meier, and P. J. Mitchell. 1995. Human cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection. J. Virol. 69:2194-2207.
42. Kurz, S. K., and M. J. Reddehase. 1999. Patchwork pattern of transcriptional reactivation in the lungs indicates sequential checkpoints in the transition from murine cytomegalovirus latency to recurrence. J. Virol. 73:8612-8622.
43. Lashmit, P., S. Wang, H. Li, H. Isomura, and M. F. Stinski. 2009. The CREB site in the proximal enhancer is critical for cooperative interaction with the other transcription factor binding sites to enhance transcription of the major intermediate-early genes in human cytomegalovirus-infected cells. J. Virol. 83:8893-8904.
44. Lee, Y., W.-J. Sohn, D.-S. Kim, and H.-J. Kwon. 2004. NF-kB- and c-Jundependent regulation of human cytomegalovirus immediate-early gene enhancer/ promoter in response to lipopolysaccharide and bacterial CpG-oligodeoxynucleotides in macrophage cell line RAW 264.7. Eur. J. Biochem. 271:1094-1105.
45. Liu, B., and M. F. Sinski. 1992. Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. J. Virol. 66:4434-4444.
46. Liu, X., et al. 2010. Phorbol ester-induced human cytomegalovirus MIE enhancer activation through PKC-delta, CREB, and NF-κB de-silences MIE gene expression in quiescently infected human pluripotent NTera2 cells. J. Virol. 84:8495-8508.
47. Meier, J. L., and J. A. Pruessner. 2000. The human cytomegalovirus major immediate-early distal enhancer region is required for efficient viral replication and immediate-early gene expression. J. Virol. 74:1602-1613.
48. Meier, J. L., and M. F. Stinski. 2006. Major immediate-early enhancer and its gene products, p. 151-166. In M. J. Reddehase (ed.), Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Wymondham, Norwich, United Kingdom.
49. Meier, J. L., M. K. Keller, and J. J. McCoy. 2002. Requirement of multiple cis-acting elements in the human cytomegalovirus major immediate-early distal enhancer for viral gene expression and replication. J. Virol. 76:313-326.
50. Messerle, M., I. Crnkovic, W. Hammerschmidt, H. Ziegler, and U. H. Koszinowski. 1997. Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc. Natl. Acad. Sci. U. S. A. 94:14759-14763.
51. Mocarski, E. S., and C. T. Courcelle. 2001. Cytomegaloviruses and their replication, p. 2629-2673. In D. M. Knipe et al. (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
52. Monick, M. M., L. J. Geist, M. F. Stinski, and G. W. Hunninghake. 1992. The immediate early genes of human cytomegalovirus upregulate expression of the cellular genes myc and fos. Am. J. Respir. Cell Mol. Biol. 7:251-256.
53. Murphy, J., W. Fischle, E. Verdin, and J. Sinclair. 2002. Control of cytomegalovirus lytic gene expression by histone acetylation. EMBO J. 21:1112-1120.
54. Muyrers, J. P., et al. 2000. Point mutation of bacterial artificial chromosomes by ET recombination. EMBO Rep. 3:239-243.
55. Netterwald, J., et al. 2005. Two gamma interferon-activated site-like elements in the human cytomegalovirus major immediate-early promoter/enhancer are important for viral replication. J. Virol. 79:5035-5046.
56. Podlech, J., et al. 2010. Enhancerless cytomegalovirus is capable of establishing a low-level maintenance infection in severely immunodeficient host tissues but fails in exponential growth. J. Virol. 84:6254-6261.
57. Presti, R. M., J. L. Pollock, A. J. Dal Canto, A. K. O'Guin, and H. W. Virgin. 1998. Interferon-g regulation of acute, chronic, and latent murine cytomegalovirus infection and disease of the great vessels. J. Exp. Med. 178:577-588.
58. Rawlinson, W. D., H. E. Farrell, and B. G. Barrell. 1996. Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 70:8833-8849.
59. Reeves, M. B., P. A. MacAri, P. J. Lehner, J. G. Sissons, and J. H. Sinclair. 2005. Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc. Natl. Acad. Sci. U. S. A. 102:4140-4145.
60. Shaulian, E., and M. Karin. 2001. AP-1 in cell proliferation and survival. Oncogene 20:2390-2400.
61. Simon, C. S., C. K. Seckert, D. Dreis, M. J. Reddehase, and N. K. A. Grzimek. 2005. Role of tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs. J. Virol. 79:326-340.
62. Sinclair, J., and P. Sissons. 2006. Latency and reactivation of HCMV. J. Gen. Virol. 87:1763-1779.
63. Stinski, M. F., and H. Isomura. 2008. Role of the cytomegalovirus major immediate early enhancer in acute infection and reactivation from latency. Med. Microbiol. Immunol. 197:223-231.
64. Wagner, M. S. Jonjic, U. H. Koszinowski, and M. Messerle. 1999. Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J. Virol. 73:7056-7060.
65. Wang, X., and G. E. Sonenshein. 2005. Induction of the RelB NF-κB subunit by the cytomegalovirus IE1 protein is mediated via Jun kinase and c-Jun/ Fra-2 AP-1 complexes. J. Virol. 79:95-105.